Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2026

Conditions
Pulmonary Arterial Hypertension
Interventions
DEVICE

V-Wave Interatrial Shunt

The V-Wave Interatrial Shunt System, includes a permanent implant placed during a minimally invasive cardiac catheterization procedure using its dedicated Delivery Catheter. The device is implanted through the fossa ovals and straddles the interatrial septum.

Trial Locations (5)

43210

WITHDRAWN

The Ohio State University Wexner Medical Center - Davis Heart & Lung Research Institute, Columbus

90033

RECRUITING

Keck Medical Center of USC, Los Angeles

94143

RECRUITING

University of California, San Francisco, San Francisco

Unknown

WITHDRAWN

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec

ACTIVE_NOT_RECRUITING

Instituto Nacional de Cardiologia, Mexico City

All Listed Sponsors
lead

V-Wave Ltd

INDUSTRY